Regulatory T cell frequencies in patients with rheumatoid arthritis are increased by conventional and biological DMARDs but not by JAK inhibitors

Ann Rheum Dis. 2021 Dec;80(12):e196. doi: 10.1136/annrheumdis-2019-216576. Epub 2019 Nov 19.

Authors

Anja Meyer^#¹, Paula S Wittekind^#¹, Konstantin Kotschenreuther¹, Joanna Schiller¹, Julia von Tresckow¹, Thomas H Haak¹, David M Kofler²

Affiliations

¹ Department I of Internal Medicine, University of Cologne, Cologne, Germany.
² Department I of Internal Medicine, University of Cologne, Cologne, Germany david.kofler@uk-koeln.de.

^# Contributed equally.

PMID: 31744827
DOI: 10.1136/annrheumdis-2019-216576

No abstract available

Keywords: T cells; cytokines; rheumatoid arthritis.

Publication types

Letter
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Antirheumatic Agents* / therapeutic use
Arthritis, Rheumatoid* / drug therapy
Humans
Janus Kinase Inhibitors* / therapeutic use
T-Lymphocytes, Regulatory

Substances

Antirheumatic Agents
Janus Kinase Inhibitors